Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Krystal Biotech Inc (KRYS)

Krystal Biotech Inc (KRYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Krystal Biotech Inc 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 USA

www.krystalbio.com P: 412-586-5830

Description:

Krystal Biotech, Inc. is a gene therapy company. It engaged in developing and commercializing novel treatments for patients suffering from dermatological diseases. Krystal Biotech, Inc. is based in Pittsburgh, United States.

Key Statistics

Overview:

Market Capitalization, $K 4,439,214
Enterprise Value, $K 4,080,884
Shares Outstanding, K 28,515
Annual Sales, $ 50,700 K
Annual Net Income, $ 10,930 K
Last Quarter Sales, $ 42,140 K
Last Quarter Net Income, $ 8,690 K
EBIT, $ -109,720 K
EBITDA, $ -105,990 K
60-Month Beta 0.85
% of Insider Shareholders 14.10%
% of Institutional Shareholders 86.29%
Float, K 24,494
% Float 85.90%
Short Volume Ratio 0.75

Growth:

1-Year Return 83.78%
3-Year Return 95.97%
5-Year Return 396.27%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -184.54%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.30 on 02/26/24
Latest Earnings Date 05/13/24
Earnings Per Share ttm -3.38
EPS Growth vs. Prev Qtr 144.78%
EPS Growth vs. Prev Year 124.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

KRYS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward 85.86
Price/Earnings to Growth N/A
Return-on-Equity % -13.31%
Return-on-Assets % -12.61%
Profit Margin % 21.56%
Debt/Equity 0.00
Price/Sales 89.46
Price/Cash Flow N/A
Price/Book 5.87
Book Value/Share 27.60
Interest Coverage -1.12
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar